Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optimizing the duration of anticoagulation therapy for venous thrombosis.

× No keyword cloud information.

10 in total

1. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.

Authors: G W Petty; R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal: Ann Intern Med Date: 1999-01-05 Impact factor: 25.391

Review 2. Optimal duration of oral anticoagulant therapy in venous thromboembolism.

Authors: S Schulman
Journal: Thromb Haemost Date: 1997-07 Impact factor: 5.249

3. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Authors: S Schulman; S Granqvist; M Holmström; A Carlsson; P Lindmarker; P Nicol; S G Eklund; S Nordlander; G Lärfars; B Leijd; O Linder; E Loogna
Journal: N Engl J Med Date: 1997-02-06 Impact factor: 91.245

4. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).

Authors: P Simioni; P Prandoni; A W Lensing; A Scudeller; C Sardella; M H Prins; S Villalta; F Dazzi; A Girolami
Journal: N Engl J Med Date: 1997-02-06 Impact factor: 91.245

5. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

Authors: S Schulman; E Svenungsson; S Granqvist
Journal: Am J Med Date: 1998-04 Impact factor: 4.965

6. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Authors: S Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
Journal: N Engl J Med Date: 1995-06-22 Impact factor: 91.245

7. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Authors: C Kearon; M Gent; J Hirsh; J Weitz; M J Kovacs; D R Anderson; A G Turpie; D Green; J S Ginsberg; P Wells; B MacKinnon; J A Julian
Journal: N Engl J Med Date: 1999-03-25 Impact factor: 91.245

8. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.

Authors: D H Ryan; M A Crowther; J S Ginsberg; C W Francis
Journal: Ann Intern Med Date: 1998-02-15 Impact factor: 25.391

9. The long-term clinical course of acute deep venous thrombosis.

Authors: P Prandoni; A W Lensing; A Cogo; S Cuppini; S Villalta; M Carta; A M Cattelan; P Polistena; E Bernardi; M H Prins
Journal: Ann Intern Med Date: 1996-07-01 Impact factor: 25.391

Review 10. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.

Authors: P M Ridker
Journal: Vasc Med Date: 1998 Impact factor: 3.239

10 in total